1. Home
  2. ENSC vs ARTW Comparison

ENSC vs ARTW Comparison

Compare ENSC & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • ARTW
  • Stock Information
  • Founded
  • ENSC 2003
  • ARTW 1956
  • Country
  • ENSC United States
  • ARTW United States
  • Employees
  • ENSC N/A
  • ARTW N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • ARTW Industrial Machinery/Components
  • Sector
  • ENSC Health Care
  • ARTW Industrials
  • Exchange
  • ENSC Nasdaq
  • ARTW Nasdaq
  • Market Cap
  • ENSC 9.5M
  • ARTW 7.8M
  • IPO Year
  • ENSC N/A
  • ARTW N/A
  • Fundamental
  • Price
  • ENSC $6.07
  • ARTW $1.53
  • Analyst Decision
  • ENSC
  • ARTW
  • Analyst Count
  • ENSC 0
  • ARTW 0
  • Target Price
  • ENSC N/A
  • ARTW N/A
  • AVG Volume (30 Days)
  • ENSC 154.9K
  • ARTW 11.9K
  • Earning Date
  • ENSC 11-12-2024
  • ARTW 10-04-2024
  • Dividend Yield
  • ENSC N/A
  • ARTW N/A
  • EPS Growth
  • ENSC N/A
  • ARTW N/A
  • EPS
  • ENSC N/A
  • ARTW N/A
  • Revenue
  • ENSC $4,421,404.00
  • ARTW $25,181,639.00
  • Revenue This Year
  • ENSC N/A
  • ARTW N/A
  • Revenue Next Year
  • ENSC N/A
  • ARTW N/A
  • P/E Ratio
  • ENSC N/A
  • ARTW N/A
  • Revenue Growth
  • ENSC 40.41
  • ARTW N/A
  • 52 Week Low
  • ENSC $2.12
  • ARTW $1.33
  • 52 Week High
  • ENSC $30.90
  • ARTW $2.37
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 42.77
  • ARTW 36.54
  • Support Level
  • ENSC $5.34
  • ARTW $1.49
  • Resistance Level
  • ENSC $8.27
  • ARTW $1.59
  • Average True Range (ATR)
  • ENSC 1.06
  • ARTW 0.06
  • MACD
  • ENSC -0.24
  • ARTW -0.01
  • Stochastic Oscillator
  • ENSC 18.43
  • ARTW 26.09

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: